Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Sep 2024 – Oct 2025Where it's discussed
-
News292 articles
-
X / Twitter187 posts
-
YouTube12 videos
-
Blogs9 articles
-
Bluesky4 posts
-
Facebook3 posts
AI synopsis
What people are saying
The group collectively recognizes the importance of the study, with numerous examples showing appreciation for the predictive power of CRP, LDL, and Lp(a) over 30 years. The tone reflects a high level of academic and clinical curiosity, using words like 'predictive,' 'significant,' and 'support,' which underscores the research's potential to impact future risk management strategies.
Most discussions support the study's findings, emphasizing the importance of combining biomarkers like CRP, LDL, and Lp(a) in predicting long-term cardiovascular risk.
The debates reflect high interest, with many commenters highlighting the significance of this long-term research and its implications for women's health.
Posts frequently mention specific biomarkers, study implications, and express appreciation or curiosity, demonstrating deep engagement with the content.
The discussions suggest this research could influence clinical practices and preventive strategies by focusing on early biomarker measurements for risk assessment.
Abstract in brief
- This study followed nearly 28,000 healthy US women over 30 years and found that higher baseline levels of CRP, LDL cholesterol, and lipoprotein(a) were all independently associated with an increased risk of major cardiovascular events like heart attacks and strokes.
- The risk predictions improved significantly when all three biomarkers were used together, indicating that each contributes unique information about cardiovascular risk over a long period.
- These findings suggest that measuring these biomarkers early in life could help identify women at higher risk for cardiovascular problems in the future, emphasizing the importance of early intervention for risk reduction.
Top posts
Most liked on X and BlueskyMeasurement of low-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and lipoprotein(a) predicted the 30-year cardiovascular disease risk among women enrolled in the Women’s Health Study. Full study results: https://t.co/SJvckaaab7 https://t.co/nLikM13rHT
A single combined measure of high-sensitivity CRP, LDL cholesterol, and lipoprotein(a) levels among initially healthy U.S. women was predictive of incident cardiovascular events during a 30-year period. https://t.co/x2t0aSEzPf
⚠️ Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women‼️
Trust the Science??? How, when it is so often pure BS? https://t.co/ja6Fe2Dw1T This 30-year observational study identified that 13% of all women between 54.7 and 85 years of age are likely to have a first-time cardiac event if their bodies are full of inflammation, they have
New in the December 5, 2024, issue of NEJM: Edoxaban Monotherapy for AF and Stable Coronary Disease (EPIC-CAD phase 3 trial) https://t.co/13c46bpne0 30-Year Cardiovascular Outcomes in Women (Women’s Health Study) https://t.co/SJvckaaab7 https://t.co/9lM32amlu0
All mentions
Reducing Heart Attack Risk Through Inflammation and Cholesterol Management
This video discusses the role of inflammation markers like CRP, LDL cholesterol, and lipoprotein(a) in predicting cardiovascular events over 30 years, highlighting early detection and intervention strategies for better…
Long-Term Impact of Inflammation and Cholesterol on Women's Heart Health
This study followed nearly 28,000 healthy US women over 30 years and found that higher levels of CRP, LDL cholesterol, and lipoprotein(a) are independently linked to increased cardiovascular risk. Early biomarker…
How to Achieve Truly Transparent Skin: Scientific Insights
Episode pilot exploring current scientific topics, including transparent skin. Discover the latest research and expert insights in live sessions. Support us via our funding links. Follow SciLaBus on YouTube, TikTok…
Blood Test Predicts Heart Disease Risk 30 Years Later
Understanding the Root Causes of Heart Disease and Long-Term Risks
This video discusses how inflammation, cholesterol, and lipoprotein(a) influence 30-year cardiovascular risks in women, highlighting the importance of early biomarker measurement for risk assessment and intervention.
Advances in Healthy Longevity and Cardiovascular Risk Prediction
Welcome to the weekly Longevity Briefing. This week, discover how three blood biomarkers can predict heart disease risk in healthy women over 30 years, and explore recent findings on the brain microbiome's role in…
Long-Term Cardiovascular Risks in Women Linked to Inflammation and Cholesterol
This study followed nearly 28,000 women over 30 years, finding higher levels of CRP, LDL cholesterol, and lipoprotein(a) were linked to increased heart attack and stroke risk. Early biomarker assessment can help…
Long-Term Cardiovascular Risk in Women: Key Biomarkers and Prevention Strategies
This episode examines a study tracking nearly 28,000 healthy women over 30 years, highlighting how biomarkers like CRP, LDL cholesterol, and lipoprotein(a) predict cardiovascular risk and the importance of early…
Long-Term Impact of Inflammation and Cholesterol on Women's Heart Health
This study followed nearly 28,000 healthy US women over 30 years, finding that higher baseline levels of CRP, LDL cholesterol, and lipoprotein(a) are independently linked to increased risk of heart attacks and strokes…
Chocolate's Role in Reducing Type 2 Diabetes Risk and Cardiovascular Prediction Advances
This episode from NB Medical explores whether chocolate consumption can lower type 2 diabetes risk, introduces a new blood test for 30-year cardiovascular risk prediction, and examines how digital GP access impacts…
SMuRF-less: CV Prevention Beyond Traditional Risk Factors
This Test Predicts Heart Attacks 30 years in Advance
@AshuPJadhav They basically already published this: https://t.co/NTW0uCr2fd
RT @HowardSchlauch: @drShaileshSingh I’d recommend monitoring hsCRP. It is useful for both acute and chronic conditions. CRP inhibits chol…
@drShaileshSingh I’d recommend monitoring hsCRP. It is useful for both acute and chronic conditions. CRP inhibits cholesterol efflux in arterial macrophages by stimulating ERK1/2, shutting down ABCA1/ABCG1; this leads to foam cell formation. Also promotes thrombosis. https://t.co/L2LFhCBIVz
@JAMACardio @hsbhatia @AlexRazavi Nonetheless Lp(a) also predicted well, independently. Getting people to check LDL, Lp(a) & hsCRP may be easier to achieve than making people calculate a risk score. The risk scores are not used often enough in clinical practice. https://t.co/kC04ekANZb
@xulabon https://t.co/Miibgm0CFu
Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women | New England Journal of Medicine https://t.co/jzZCNm5DGK
RT @SantasEnrique: Estos resultados apoyan la utilidad de combinar estos 3 biomarcadores en prevención primaria
RT @SantasEnrique: Estos resultados apoyan la utilidad de combinar estos 3 biomarcadores en prevención primaria
Estos resultados apoyan la utilidad de combinar estos 3 biomarcadores en prevención primaria
RT @GregoryPontone: Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women | New England Journal of Medici…
RT @aklfahed: “A single combined measure of high-sensitivity CRP, LDL cholesterol, and lipoprotein(a) levels among initially healthy U.S. w…
High-sensitivity C-reactive protein (CRP), low-density lipoprotein (LDL) cholesterol, and lipoprotein(a) levels contribute to 5-year and 10-year predictions of … Source: The New England Journal of Medicine https://t.co/8O0maPuTw6
RT @reginadalmau: Inflammation, Cholesterol, Lp(a), and 30-Year CV Outcomes in Women | New England Journal of Medicine https://t.co/eJ5kl9J…
Inflammation, Cholesterol, Lp(a), and 30-Year CV Outcomes in Women | New England Journal of Medicine https://t.co/eJ5kl9Jzv1 A single combined measure of hs CRP, LDLc , and lp(a) levels among healthy U.S. women was predictive of incident CV events during a 30-y period.
CRP, Lp(a) and cholesterol highly predictive of CV events in women https://t.co/cdL3XKKr0K
Inflamación, colesterol, lipoproteína(a) y resultados cardiovasculares tras 30 años en mujeres https://t.co/fP9aAp56Aw PMID 39216091
【衝撃】 心疾患の予防のために LDLコレステロールを下げよう というのは常識になっていますが、 好感度CRP、リポタンパク質(a) も合わせると 30年後のリスク評価できるそうです! #医学 #心疾患 #動脈硬化 https://t.co/3ob87BvoeC
https://t.co/rItDm2vG9R
RT @GeorgeMetsios: hsCRP, LDL cholesterol, and lipoprotein(a) levels among initially healthy women may predict cardiovascular event inciden…
hsCRP, LDL cholesterol, and lipoprotein(a) levels among initially healthy women may predict cardiovascular event incident during a 30-year period https://t.co/EgOVPbn4yL
RT @DanielJDrucker: A single combined measure of high-sensitivity CRP, LDL cholesterol, and lipoprotein(a) levels among initially healthy U…
In a 30-year study of 27,939 initially healthy women, baseline levels of high-sensitivity CRP, LDL cholesterol, and lipoprotein(a) independently predicted long-term cardiovascular risk. https://t.co/ROWTM8Lfw4 https://t.co/s29Fmq5w6g
RT @JTLLERGO: ⚠️ Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women‼️
RT @JTLLERGO: ⚠️ Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women‼️
RT @JTLLERGO: ⚠️ Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women‼️
RT @DanielJDrucker: A single combined measure of high-sensitivity CRP, LDL cholesterol, and lipoprotein(a) levels among initially healthy U…
RT @0waki: 最大でHR 1.7くらいの開きじゃ、知ってもあまり意味ないですね。次の30年で再現されるとも思えない。 Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outco…
最大でHR 1.7くらいの開きじゃ、知ってもあまり意味ないですね。次の30年で再現されるとも思えない。 Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women | New England Journal of Medicine https://t.co/6q7WhPe98d
https://t.co/Sq6pW5cGvY
30-Year prediction ! Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women | New England Journal of Medicine www.nejm.org/doi/full/10....
Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women | New England Journal of Medicine https://t.co/p7JOauh5mq
30-year prediction ! A single combined measure of high-sensitivity CRP, LDL cholesterol, and lipoprotein(a) levels among initially healthy U.S. women was predictive of incident cardiovascular events during a 30-year period. https://t.co/p7JOauh5mq
RT @DanielJDrucker: A single combined measure of high-sensitivity CRP, LDL cholesterol, and lipoprotein(a) levels among initially healthy U…
Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women | New England Journal of Medicine https://t.co/wjCOsKgfuh
RT @NEJM: Measurement of low-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and lipoprotein(a) predicted the 30-year…
RT @NEJM: Measurement of low-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and lipoprotein(a) predicted the 30-year…
RT @NEJM: Measurement of low-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and lipoprotein(a) predicted the 30-year…
RT @JTLLERGO: ⚠️ Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women‼️
RT @JTLLERGO: ⚠️ Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women‼️
RT @DanielJDrucker: A single combined measure of high-sensitivity CRP, LDL cholesterol, and lipoprotein(a) levels among initially healthy U…
Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women | New England Journal of Medicine https://t.co/s0T2gmR2vM Congrats Dr Ridker and his team. @Drlipid would love your insights, as always.
RT @NEJM: Measurement of low-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and lipoprotein(a) predicted the 30-year…
RT @NEJM: Measurement of low-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and lipoprotein(a) predicted the 30-year…
RT @JTLLERGO: ⚠️ Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women‼️
RT @JTLLERGO: ⚠️ Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women‼️
RT @JTLLERGO: ⚠️ Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women‼️
RT @DanielJDrucker: A single combined measure of high-sensitivity CRP, LDL cholesterol, and lipoprotein(a) levels among initially healthy U…
RT @JTLLERGO: ⚠️ Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women‼️
RT @JTLLERGO: ⚠️ Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women‼️
⚠️ Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women‼️
RT @DanielJDrucker: A single combined measure of high-sensitivity CRP, LDL cholesterol, and lipoprotein(a) levels among initially healthy U…
RT @DanielJDrucker: A single combined measure of high-sensitivity CRP, LDL cholesterol, and lipoprotein(a) levels among initially healthy U…
RT @NEJM: New in the December 5, 2024, issue of NEJM: Edoxaban Monotherapy for AF and Stable Coronary Disease (EPIC-CAD phase 3 trial) h…
New in the December 5, 2024, issue of NEJM: Edoxaban Monotherapy for AF and Stable Coronary Disease (EPIC-CAD phase 3 trial) https://t.co/13c46bpne0 30-Year Cardiovascular Outcomes in Women (Women’s Health Study) https://t.co/SJvckaaab7 https://t.co/9lM32amlu0
RT @DanielJDrucker: A single combined measure of high-sensitivity CRP, LDL cholesterol, and lipoprotein(a) levels among initially healthy U…
RT @NEJM: Measurement of low-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and lipoprotein(a) predicted the 30-year…
RT @NEJM: Measurement of low-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and lipoprotein(a) predicted the 30-year…
RT @DanielJDrucker: A single combined measure of high-sensitivity CRP, LDL cholesterol, and lipoprotein(a) levels among initially healthy U…
RT @NEJM: Measurement of low-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and lipoprotein(a) predicted the 30-year…
Un análisis de sangre podría predecir el riesgo de desarrollar enfermedades cardiovasculares incidentes durante un periodo de 30 años en mujeres.
RT @NEJM: Measurement of low-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and lipoprotein(a) predicted the 30-year…
RT @NEJM: Measurement of low-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and lipoprotein(a) predicted the 30-year…
Inflammation, Cholesterol, Lipoprotein(a), and 30-Year CVO in Women | NEJM. La PCR Us, el cLDL y los niveles del Lp(a) predicen ECV a 30 años en mujeres. Los usamos para valorar el objetivo de LDL en prev primaria. @LipidoSeen @sea_es https://t.co/tjhXFLvnRV
Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women | New England Journal of Medicine https://t.co/8GIi9I582v
RT @NEJM: Measurement of low-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and lipoprotein(a) predicted the 30-year…
RT @florencarral: Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women | New England Journal of Medicine…
Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women https://t.co/jjnIsW9c9Z #prevention #LPA #CRP #LDL via @NEJM
RT @NEJM: Measurement of low-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and lipoprotein(a) predicted the 30-year…
RT @NEJM: Measurement of low-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and lipoprotein(a) predicted the 30-year…
Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women | New England Journal of Medicine https://t.co/gOQ9S9oXIH
RT @NEJM: Measurement of low-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and lipoprotein(a) predicted the 30-year…
High-sensitivity C-reactive protein (CRP), low-density lipoprotein (LDL) cholesterol, and lipoprotein(a) levels contribute to 5-year and 10-year predictions of … Source : The New England Journal of Medicine https://t.co/vquTPl0RMl
RT @DanielJDrucker: A single combined measure of high-sensitivity CRP, LDL cholesterol, and lipoprotein(a) levels among initially healthy U…
RT @NEJM: Measurement of low-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and lipoprotein(a) predicted the 30-year…
RT @DanielJDrucker: A single combined measure of high-sensitivity CRP, LDL cholesterol, and lipoprotein(a) levels among initially healthy U…
RT @DanielJDrucker: A single combined measure of high-sensitivity CRP, LDL cholesterol, and lipoprotein(a) levels among initially healthy U…
A single combined measure of high-sensitivity CRP, LDL cholesterol, and lipoprotein(a) levels among initially healthy U.S. women was predictive of incident cardiovascular events during a 30-year period. https://t.co/x2t0aSEzPf
The problem with being 30 years ahead is that it takes 30 years to show you were right. www.nejm.org/doi/full/10.1056/NEJMoa2405182?query=TOC
RT @NEJM: Measurement of low-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and lipoprotein(a) predicted the 30-year…
RT @NEJM: Measurement of low-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and lipoprotein(a) predicted the 30-year…
【CVイベント初発の至適予知マーカーは?/ NEJM】 米国、健常女性27,939名 [平均54.7歳] 、30年観察:13.1%にMACE。hs-CRP、LDL-C、Lp(a)はいずれも独立したリスクマーカー。リスク上昇を最も俊敏に捉えたのは3つを混合したモデル。 https://t.co/dGg09jTfFh https://t.co/LQaIdclQAV
RT @NEJM: Measurement of low-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and lipoprotein(a) predicted the 30-year…
RT @NEJM: Measurement of low-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and lipoprotein(a) predicted the 30-year…
RT @NEJM: Measurement of low-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and lipoprotein(a) predicted the 30-year…
RT @NEJM: Measurement of low-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and lipoprotein(a) predicted the 30-year…
RT @NEJM: Measurement of low-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and lipoprotein(a) predicted the 30-year…
Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women high-sensitivity CRP, LDL cholesterol, and lipoprotein(a) levels among initially healthy U.S. women predictive incident cardiovascular events during a 30-year period https://t.co/KUiV9OvR2z https://t.co/CrdciqSR31
RT @NEJM: Measurement of low-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and lipoprotein(a) predicted the 30-year…
Measurement of low-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and lipoprotein(a) predicted the 30-year cardiovascular disease risk among women enrolled in the Women’s Health Study. Full study results: https://t.co/SJvckaaab7 https://t.co/nLikM13rHT
RT @Scilabus: Allez, on tente des vidéos d'actu scientifique ? On a fait un épisode pilote avec @Thomas_Mln_SALC . Ça vous intéresse ? On c…
Comment rendre la peau transparente ? (pour de vrai) https://t.co/HagKbsxEB9 via @YouTube
RT @cardio_tu: 2 min cardiology(臨床、担当:進藤智彦) Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women Paul…
@TiboLeroyInFr 10.1056/NEJMoa2405182 #bienvenueagattaca
Comment rendre la peau transparente ? (pour de vrai) https://t.co/X2nzvJZ57O
https://t.co/vVcoXmAF5c
https://t.co/4izBxxY2D9
Allez, on tente des vidéos d'actu scientifique ? On a fait un épisode pilote avec @Thomas_Mln_SALC . Ça vous intéresse ? On continue ? https://t.co/EbXCiATHNL
2 min cardiology(臨床、担当:進藤智彦) Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women Paul M Ridker et al. NEJM Aug 31st 2024 https://t.co/800KiTlKV2 →
RT @WitchDrTim: Trust the Science??? How, when it is so often pure BS? https://t.co/ja6Fe2Dw1T This 30-year observational study identifie…
RT @WitchDrTim: Trust the Science??? How, when it is so often pure BS? https://t.co/ja6Fe2Dw1T This 30-year observational study identifie…
Trust the Science??? How, when it is so often pure BS? https://t.co/ja6Fe2Dw1T This 30-year observational study identified that 13% of all women between 54.7 and 85 years of age are likely to have a first-time cardiac event if their bodies are full of inflammation, they have
https://t.co/hxnPzlmYLQ #inflammation
RT @EricTopol: Beyond LDL cholesterol, the importance of inflammation (as reflected by hs-CRP) and Lp(a) for determining risk of adverse ca…
RT @EricTopol: Beyond LDL cholesterol, the importance of inflammation (as reflected by hs-CRP) and Lp(a) for determining risk of adverse ca…
RT @EricTopol: Beyond LDL cholesterol, the importance of inflammation (as reflected by hs-CRP) and Lp(a) for determining risk of adverse ca…
Key findings from a new study reveal high-sensitivity C-reactive protein (hs-CRP) to be a significant biomarker predicting cardiovascular risk. Explore the full study in this @nejm article: https://t.co/SWBsuuppgz #healthcareinnovation
RT @drpablocorral:
Inflamación, colesterol, lipoproteína(a) y resultados cardiovasculares a 30 años en mujeres | Revista de Medicina de Nueva Inglaterra https://t.co/i9KoU9hJai
(CRP), düşük yoğunluklu lipoprotein (LDL) kolesterol ve lipoprotein(a) seviyeleri, kardiyovasküler riskin 5 yıllık ve 10 yıllık tahminlerine katkıda bulunuyor. New England Journal of Medicine https://t.co/DXljUiMs1Y
➡️ Die Studie dazu im renommierten "New England Journal of Medicine" pubmed.ncbi.nlm.nih.gov/39216091/ 2/2
➡️ Die Studie dazu im renommierten "New England Journal of Medicine" pubmed.ncbi.nlm.nih.gov/39216091/ 2/2
➡️ Die Studie dazu im renommierten "New England Journal of Medicine" https://t.co/hO5BXYijH6 2/2
RT @timspector: Low level Inflammation in blood is a more important marker of 30 year mortality or heart disease than LDL- cholesterol and…
Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women | New England Journal of Medicine https://t.co/G8tTNVenDi
Know your hsCRP and Lipoprotein (a) Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women | New England Journal of Medicine #WomenHealth #Inflammation #Cholesterol #LpA https://t.co/NMUhEK00Lq
RT @AnastasiaSMihai: Inflammation, Cholesterol, Lp(a), & 30-Year Cardiovascular Outcomes in Women in @NEJM Thank you Dr Ridker & coauthor…
RT @AnastasiaSMihai: Inflammation, Cholesterol, Lp(a), & 30-Year Cardiovascular Outcomes in Women in @NEJM Thank you Dr Ridker & coauthor…
Inflammation, Cholesterol, Lp(a), & 30-Year Cardiovascular Outcomes in Women in @NEJM Thank you Dr Ridker & coauthors for
RT @drpablocorral:
RT @drpablocorral:
RT @drpablocorral:
RT @drpablocorral:
RT @drpablocorral:
RT @drpablocorral:
RT @drpablocorral:
RT @drpablocorral:
RT @drpablocorral:
RT @drpablocorral:
RT @drpablocorral:
RT @agingdoc1: Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women A single combined measure of high-s…
Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women A single combined measure of high-sensitivity CRP, LDL cholesterol, and lipoprotein(a) levels was predictive of incident cardiovascular events over a 30-year period. https://t.co/8FS7IgeGOC
RT @drpablocorral:
RT @drpablocorral:
RT @drpablocorral:
RT @drpablocorral:
RT @drpablocorral:
RT @drpablocorral:
RT @drpablocorral:
RT @drpablocorral:
RT @drpablocorral:
RT @drpablocorral:
RT @drpablocorral:
RT @drpablocorral:
RT @drpablocorral:
RT @drpablocorral:
RT @drpablocorral:
RT @drpablocorral:
RT @drpablocorral:
RT @drpablocorral:
RT @drpablocorral:
RT @drpablocorral:
RT @drpablocorral:
RT @drpablocorral:
RT @drpablocorral:
RT @drpablocorral:
Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women. https://t.co/9kE9SuaNPR
Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women https://t.co/UB5F6G2km6
Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women | New England Journal of Medicine https://t.co/4eUgGw4mNG
Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women | New England Journal of Medicine https://t.co/QooesEM64I
NEJM at ESC — Inflammation, Cholesterol, Lipoprotein(a) and 30-Year Cardiovascular Outcomes in Women #science #publication #research #journal https://t.co/ABhOZCkDxf
RT @NEJM: Original Article: Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women https://t.co/SJvckaaab7…
Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women | New England Journal of Medicine https://t.co/FoYpJy12Tw
RT @NEJM: Original Article: Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women https://t.co/SJvckaaab7…
RT @NEJM: Original Article: Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women https://t.co/SJvckaaab7…
RT @NEJM: Original Article: Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women https://t.co/SJvckaaab7…
RT @drbennisahmed: Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women high-sensitivity CRP, LDL chole…
RT @NEJM: Original Article: Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women https://t.co/SJvckaaab7…
RT @NEJM: Original Article: Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women https://t.co/SJvckaaab7…
RT @NEJM: Original Article: Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women https://t.co/SJvckaaab7…
Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women #science #publication #research #journal https://t.co/1fpm179dqi
RT @NEJM: Original Article: Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women https://t.co/SJvckaaab7…
RT @DrDamluji: Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women: @NEJM
RT @NEJM: Original Article: Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women https://t.co/SJvckaaab7…
RT @NEJM: Original Article: Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women https://t.co/SJvckaaab7…
RT @DrDamluji: Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women: @NEJM
RT @NEJM: Original Article: Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women https://t.co/SJvckaaab7…
Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women high-sensitivity CRP, LDL cholesterol, and lipoprotein(a) levels among initially healty women was predictive of incident cardiovascular events during a 30-year https://t.co/KUiV9OvR2z https://t.co/SBcB7rJxr1
RT @DrDamluji: Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women: @NEJM
Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women | New England Journal of Medicine https://t.co/wjCOsKgfuh
RT @NEJM: Original Article: Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women https://t.co/SJvckaaab7…
RT @DrDamluji: Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women: @NEJM
RT @NEJM: Original Article: Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women https://t.co/SJvckaaab7…
RT @DrDamluji: Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women: @NEJM
RT @NEJM: Original Article: Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women https://t.co/SJvckaaab7…
RT @DrDamluji: Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women: @NEJM
RT @DrDamluji: Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women: @NEJM
RT @DrDamluji: Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women: @NEJM
RT @DrDamluji: Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women: @NEJM
AE
DC
J
AA